10 Health Care Stocks Whale Activity In Today’s Session
This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums…
Bristol-Myers Squibb’s Options: A Look at What the Big Money is Thinking
Deep-pocketed investors have adopted a bearish approach towards Bristol-Myers Squibb (NYSE:BMY), and it’s something market players shouldn’t ignore.…
Are Boomers Crashing The Economy Or Saving It? Why Investors Are Perplexed And What You Can Do To Prepare
Mass retirement of boomers could have major economic impact. Experts anticipate both risks and opportunities from the largest wealth transfer in history.
10 Health Care Stocks With Whale Alerts In Today’s Session
This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums…
Wall Street’s Most Accurate Analysts Say Hold These 3 Health Care Stocks With Over 4% Dividend Yields
During times of turbulence and uncertainty in the markets, even when markets are at all-time highs, many investors…
10 Health Care Stocks With Whale Alerts In Today’s Session
This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums…
What’s Going On With Mid-Cap Cancer-Focused Verastem Oncology Stock On Friday?
Verastem Oncology reports promising initial results from the RAMP 205 trial with an 83% ORR for avutometinib and defactinib in metastatic pancreatic cancer. FDA submission for recurrent KRAS mutant ovarian cancer is underway.
(BMY) – Analyzing Bristol-Myers Squibb’s Short Interest
Bristol-Myers Squibb’s (NYSE:BMY) short percent of float has fallen 18.82% since its last report. The company recently reported…
Hawaii Court Rules Against Bristol Myers, Sanofi In Blood Clot Drug Case, Increases Liability To $916M
A Hawaii judge has ordered Bristol Myers Squibb and Sanofi to pay $916 million for not warning non-white patients about the health risks of their blood thinner Plavix. The ruling follows a previous $834 million judgment
Spotlight on Bristol-Myers Squibb: Analyzing the Surge in Options Activity
Whales with a lot of money to spend have taken a noticeably bearish stance on Bristol-Myers Squibb. Looking…